【削除禁止】主要プログラム（ペット）

RQ-00000010 is a novel, highly potent and highly selective 5-HT_{4} agonist. The neurotransmitter serotonin (5-HT) promotes intestinal motility via 5-HT_{4}, one of the receptors in the digestive system, and its agonist is considered useful as a treatment for intestinal motility disorders. RaQualia has achieved good results in terms of both efficacy and safety in the development of this product so far, and expects that further development by the licensee will lead to a breakthrough new drug first for dogs and cats for which treatment options are limited.